Survey: Biotech and drug executives expect increase in M&A

05/17/2010 | Wall Street Journal, The

More than eight in 10 biotech and pharmaceutical executives said major drug companies increasingly will rely on mergers and acquisitions to fill gaps in innovation, according to a survey by intellectual-property group Marks & Clerk. "Pharmaceutical companies may now have confidence and the support of institutional investors to press ahead with acquisitions, although at this stage, selecting the right acquisition targets will be critical to their future [research and development] success," a Marks & Clerk official said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA